Detalles de la búsqueda
1.
Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
J Med Virol
; 95(6): e28884, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342886
2.
Heterogeneity assessment of vaccine-induced effects using point-of-care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2.
J Clin Lab Anal
; 36(7): e24545, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678628
3.
Effects of 1-year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes.
Diabetes Obes Metab
; 23(12): 2614-2622, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338409
4.
Survey of the current status of subclinical coronavirus disease 2019 (COVID-19).
J Infect Chemother
; 26(12): 1294-1300, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958395
5.
Tofogliflozin decreases body fat mass and improves peripheral insulin resistance.
Diabetes Obes Metab
; 20(5): 1311-1315, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29316197
6.
Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc).
BMC Endocr Disord
; 15: 46, 2015 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26353820
7.
Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.
BMC Endocr Disord
; 15: 34, 2015 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137940
8.
A survey of clinical physician's perceptions of stigma and advocacy in patients with type 2 diabetes in Kanagawa, Japan.
J Diabetes Investig
; 13(12): 2073-2080, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980305
9.
Multinational Observational Study to Understand Insulin Treatment Intensification: Japanese Subgroup Analysis of the MOSAIc Study.
Diabetes Ther
; 13(2): 265-274, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34988917
10.
Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Intern Med
; 61(2): 159-165, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34744105
11.
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Intern Med
; 61(20): 3053-3062, 2022 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945024
12.
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection.
Open Forum Infect Dis
; 9(2): ofab626, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35071683
13.
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors.
Front Microbiol
; 12: 661187, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34025615
14.
Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients.
Endocr J
; 57(6): 499-507, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20208396
15.
A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes.
J Clin Med Res
; 12(3): 200-208, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231757
16.
Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study.
Diabetes Technol Ther
; 22(3): 228-234, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013567
17.
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.
J Diabetes Investig
; 11(5): 1248-1257, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32149469
18.
Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus.
J Clin Med Res
; 11(9): 651-663, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31523339
19.
Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study.
J Clin Med Res
; 11(5): 311-320, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31019624
20.
Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.
J Diabetes Investig
; 9(6): 1323-1332, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603684